The Wall Street Journal reports on healthcare companies’ probes of readily available information from data brokers, pharmacies and social networks in order to recruit patients for clinical trials. Blue Chip Marketing Worldwide, for example, found patients to experiment with an obesity drug by targeting people who presumably live sedentary lifestyles, such as those who subscribe to premium cable TV or eat at fast-food chains frequently, the report states. “We are now at a point where, based on your credit-card history … we can get a very, very close read on whether or not you have the disease we’re looking at,” said a spokesman from one pharmaceutical product development company. (Registration may be required to access this story.)
If you want to comment on this post, you need to login.